The Screening Tomosynthesis Trial with Advanced Reader Methods (STREAM): design and rationale of a population-based breast cancer screening trial - Scorecard - MDSpire

The Screening Tomosynthesis Trial with Advanced Reader Methods (STREAM): design and rationale of a population-based breast cancer screening trial

  • By

  • Lindy Kregting

  • Daan van den Oever

  • Lian Pennings

  • Ruud Pijnappel

  • Nicolien van Ravesteyn

  • Ellen Verschuur

  • Marja van Oirsouw

  • Loes Dunning

  • Hans ‘t Mannetje

  • Ruben van Engen

  • Adriana Bluekens

  • Maartje Smid-Geirnaerdt

  • Cary van Landsveld-Verhoeven

  • Nehmat Houssami

  • Ioannis Sechopoulos

  • Mireille Broeders

  • January 9, 2025

  • 0 min

Share

Clinical Scorecard: Design and Justification of the STREAM Trial: A Population-Based Study on Breast Cancer Screening Utilizing Advanced Reader Techniques

At a Glance

CategoryDetail
ConditionBreast cancer screening
Key MechanismsComparison of digital mammography (DM) and digital breast tomosynthesis (DBT) with synthetic mammography (SM) using double reading and advanced interpretation strategies
Target PopulationAsymptomatic women aged 49 to 75 years invited for breast cancer screening in the Netherlands
Care SettingPopulation-based breast cancer screening program in mobile and fixed screening units

Key Highlights

  • STREAM is a prospective, non-randomised, parallel-group trial embedded in the Dutch breast cancer screening programme comparing two rounds of DBT screening to DM screening.
  • DBT screening aims to improve cancer detection rates and optimize reading time using advanced techniques including AI-aided navigation and modified image acquisition.
  • Primary outcomes include participation rate, recall rate, detection rate, positive predictive value, interval cancer rates, advanced cancer detection, and cost-effectiveness.

Guideline-Based Recommendations

Diagnosis

  • Use biennial digital mammography (DM) with craniocaudal (CC) and mediolateral-oblique (MLO) views double-read independently by two radiologists.
  • In the STREAM trial, DBT with synthetic mammography (SM) and double reading is used to potentially improve detection rates.

Management

  • Women with suspicious findings on screening are referred for diagnostic work-up at hospitals.
  • DBT screening interpretation strategies include using MLO views without CC, thicker image slabs, AI-aided navigation, and possibly replacing one reader with AI to reduce workload.

Monitoring & Follow-up

  • Monitor participation rates, recall rates, detection rates, positive predictive values, interval cancer rates, and advanced cancer detection in screening rounds.
  • Evaluate long-term outcomes including breast cancer mortality, overdiagnosis, and cost-effectiveness.

Risks

  • Potential increase in recall rates with DBT screening in settings with already low recall rates like the Netherlands.
  • Uncertainty regarding impact of DBT on interval cancer rates and cost-effectiveness in the Dutch screening context.

Patient & Prescribing Data

Women aged 49 to 72 invited for breast cancer screening in selected Dutch screening units.

DBT screening involves two-view imaging (CC and MLO) with double reading; participation requires informed consent; exclusion only if wheelchair-bound.

Clinical Best Practices

  • Ensure radiologists and radiographers receive specific training on DBT image acquisition and interpretation prior to trial initiation.
  • Use double reading with arbitration or consensus to resolve discrepancies in image interpretation.
  • Incorporate previous DM images for comparison when available to improve diagnostic accuracy.
  • Optimize DBT reading time by employing advanced reading methods such as AI assistance and modified image acquisition protocols.

References

Original Source(s)

Related Content